GLOW

GLOW (70mg) — Three-Peptide Skin and Tissue-Repair Research Blend

Omega Peptides Australia supplies GLOW (70mg) in Australia from domestic stock, dispatching same day on orders placed before 12pm with a certificate of analysis published for every batch. Often written GLOW peptide, GLOW peptides, GLOW blend or glowing peptide, it is a three-peptide blend combining GHK-Cu, BPC-157 and TB-500 in a single vial.

GLOW is a multi-peptide research blend that combines three separately studied peptides in one lyophilised vial: 50mg of GHK-Cu (the copper-binding tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973), 10mg of BPC-157 (a fifteen-amino-acid pentadecapeptide derived from a protective protein in gastric juice) and 10mg of TB-500 (a synthetic peptide based on the actin-binding region of thymosin beta-4), for 70mg of peptide in total. It is often written as GLOW peptide, glow blend or glow 70, and sometimes described simply as the GHK-Cu BPC-157 TB-500 blend. The name is a coined product name that reflects the skin and collagen focus of its largest component.

GLOW is studied in two main directions: skin and collagen remodelling, driven by GHK-Cu, and soft-tissue repair and angiogenesis, driven by BPC-157 and TB-500. At the pathway level the three components act through distinct mechanisms, from copper delivery and gene modulation in fibroblasts to growth-factor and nitric-oxide signalling in endothelial cells and regulation of the actin cytoskeleton, which is the rationale for combining them in a single research vial.

Omega Peptides Australia supplies GLOW as a high-purity (≥99% HPLC) COA-verified lyophilised powder in a sealed sterile vial. Orders placed before 12pm are dispatched the same day from within Australia, and the Certificate of Analysis for each batch is published in our COA library. Researchers looking to buy the GLOW blend in Australia get verified material and domestic stock with no customs delays.

Key research areas

• Skin and collagen remodelling GHK-Cu has been studied in fibroblast cultures and skin models for its effect on collagen, elastin and glycosaminoglycan synthesis, and on the balance between matrix metalloproteinases and their tissue inhibitors. It is proposed to act by delivering copper to cells, where it is a cofactor for the collagen-crosslinking enzyme lysyl oxidase, and by modulating the expression of genes involved in tissue remodelling.
• Wound healing All three components have been investigated in wound models. GHK-Cu has been studied in dermal wound and ulcer models, full-length thymosin beta-4 has progressed through Phase 2 clinical programmes for chronic dermal wounds, and BPC-157 has been examined in rodent skin-wound and burn models.
• Tendon, ligament and muscle repair BPC-157 and TB-500 are the most frequently paired peptides in preclinical connective-tissue research. BPC-157 is proposed to increase fibroblast outgrowth and collagen deposition through FAK-paxillin signalling, while TB-500 regulates the actin cytoskeleton that cells need in order to migrate into an injury site.
• Angiogenesis New vessel formation is a shared endpoint across the blend. BPC-157 activates VEGFR2 and nitric-oxide signalling in endothelial cells, thymosin beta-4 promotes endothelial cell migration and tube formation, and GHK-Cu has been reported to increase VEGF expression in cultured cells.
• Hair follicle research GHK-Cu and thymosin beta-4 have each been studied in rodent hair-growth models, where the proposed mechanisms include increased follicle size, stem-cell activation and improved blood supply to the follicle.
• Antioxidant and anti-inflammatory signalling GHK-Cu has been studied for antioxidant effects, including supply of copper to superoxide dismutase and modulation of inflammatory cytokines, while thymosin beta-4 has been reported to reduce NF-κB activation in injured tissue.

GLOW in Australia

GLOW is supplied in Australia strictly as a research-grade lyophilised vial; it is not a registered medicine and is not available through Chemist Warehouse, Priceline or compounding pharmacies. Omega Peptides Australia holds it in domestic stock, dispatches same day on orders before 12pm, and ships on tracked delivery within Australia, so there is no international transit or customs hold. Each batch carries an independent certificate in the COA library matched to the number printed on the vial.

GLOW is stocked in Australia as a 70mg vial. Its three components, GHK-Cu, BPC-157 and TB-500, are each held individually, and the four-peptide KLOW blend adds KPV. A GLOW bundle pairs the vial with diluent and consumables.

How GLOW works

Each component of GLOW works through a different mechanism. GHK-Cu binds copper(II) with high affinity and carries it into cells, where copper is required by lysyl oxidase for collagen and elastin crosslinking and by superoxide dismutase for antioxidant defence; in fibroblast studies it also alters the expression of a large number of genes governing matrix synthesis, breakdown and repair. BPC-157 activates VEGFR2 and the Akt-eNOS pathway in endothelial cells, increasing nitric-oxide production and angiogenesis, and triggers the FAK-paxillin pathway in fibroblasts, increasing their migration and collagen output. TB-500 reproduces the Leu-Lys-Lys-Thr-Glu-Thr-Gln motif of thymosin beta-4 that binds G-actin, regulating cytoskeletal remodelling so that cells can move and divide during repair.

GLOW is available in two forms. This 70mg single vial contains all three peptides pre-combined in fixed amounts, so one reconstitution gives a solution containing all three. The GLOW Peptide Bundle supplies the same three peptides as separate vials, which suits studies that need each compound at its own concentration or want to run single-compound controls. For an anti-inflammatory tripeptide in the same base, the KLOW blend adds 10mg of KPV. Human pharmacokinetic data for the individual peptides are limited, and none of the three is an approved medicine.

Specifications

Available sizes and pricing

GLOW is supplied in a single 70mg vial containing all three peptides in fixed amounts. The same three compounds are also available as separate vials in the GLOW Peptide Bundle at $189.99, and buying them individually (GHK-Cu 50mg at $89.99, BPC-157 10mg at $99.99 and TB-500 10mg at $99.99) would cost $289.97, so the single blended vial is the lowest cost per mg of the three options.

• 70mg vial (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) — $139.99 (about $2.00 per mg)

Quality and COA verification

Every batch of GLOW is independently tested by Janoshik Analytical. HPLC confirms purity, and mass spectrometry confirms the identity of each peptide in the blend by matching its measured mass to the expected molecular weight. A Certificate of Analysis is issued for every batch and published in our COA library, where the batch number printed on your vial can be checked against the report. The blend is lyophilised for long-term stability, sealed in a sterile vial and packed in protective packaging for domestic transit.

Frequently bought together

• KLOW (80mg) — $149.99, the same three peptides plus 10mg of KPV for an anti-inflammatory component
• GHK-Cu (50mg) — $89.99, the copper tripeptide on its own for skin and collagen controls
• GLOW Peptide Bundle — $189.99, GHK-Cu, BPC-157 and TB-500 supplied as separate vials
• Bacteriostatic Water (10mL) — $29.99, for reconstituting the lyophilised blend

Research guides

• GHK-Cu research guide
• BPC-157 vs TB-500
• How to store lyophilised peptides
• COA testing explained
• Peptide reconstitution calculator
• Certificates of Analysis library

Frequently asked questions

What is GLOW?
GLOW is the product name for a three-peptide research blend supplied as a single 70mg lyophilised vial. The name is coined rather than chemical and reflects the skin and collagen focus of GHK-Cu, its largest component. References to the GLOW peptide, glow blend or glow 70 all mean this specific combination of GHK-Cu, BPC-157 and TB-500 in fixed amounts.

What is in the GLOW peptide blend?
Each vial contains 50mg of GHK-Cu, the copper-binding tripeptide glycyl-L-histidyl-L-lysine; 10mg of BPC-157, a pentadecapeptide derived from a gastric protective protein; and 10mg of TB-500, a synthetic peptide based on the actin-binding region of thymosin beta-4. The total is 70mg of peptide, supplied as lyophilised powder in a sealed sterile vial.

What is GLOW also known as?
It is also written as GLOW peptide, glow blend, glow 70 or Glow 70mg, and described as the GHK-Cu BPC-157 TB-500 blend. The components have their own aliases: GHK-Cu is called copper peptide or copper tripeptide-1, BPC-157 is written BPC 157, BPC157 or bcp 157, and TB-500 is written TB500 or described as a thymosin beta-4 fragment.

How does GLOW work?
Each component acts differently. GHK-Cu delivers copper to cells, supporting lysyl oxidase-dependent collagen crosslinking and superoxide dismutase activity, and modulates gene expression involved in matrix remodelling. BPC-157 activates VEGFR2 and nitric-oxide signalling and the FAK-paxillin pathway, promoting angiogenesis and fibroblast migration. TB-500 binds G-actin to regulate cytoskeletal remodelling and cell migration. The blend allows these three signals to be studied together in one preparation.

What does the research show about GLOW?
GLOW has not been studied as a fixed combination in published trials; the evidence relates to its components. GHK-Cu has been reported to increase collagen and glycosaminoglycan synthesis in fibroblasts and to modulate remodelling genes, BPC-157 has been studied across rodent tendon, muscle and gastrointestinal models, and thymosin beta-4 has reached Phase 2 clinical programmes in dermal wounds and ophthalmic conditions. All three remain investigational research compounds.

Can I buy GLOW at Chemist Warehouse or a pharmacy in Australia?
No. GLOW is not a registered medicine and none of its three peptides is stocked by Chemist Warehouse, Priceline or other retail pharmacies. Topical cosmetic serums containing small percentages of GHK-Cu are sold by beauty retailers and some pharmacies, but those are cosmetics; the lyophilised research blend supplied here is a laboratory reagent, not a cosmetic or medicine.

Can Australian compounding pharmacies supply GLOW?
Compounding pharmacies in Australia prepare medicines only for an individual patient on a practitioner's prescription and do not sell peptides to the public. Omega Peptides Australia is not a pharmacy. We supply the lyophilised research blend with a batch COA, strictly for in-vitro laboratory use.

How do you reconstitute GLOW?
Use bacteriostatic water. Swab the stopper, then add the chosen volume of water slowly down the inside wall of the vial so it runs onto the powder rather than jetting into it. Swirl gently until the solution is clear, do not shake, because agitation can fragment the peptides. GHK-Cu gives the solution a faint blue tint, which is normal. Label the vial with the date and concentration, refrigerate at 2–8°C and use within 28 days.

How should GLOW be stored?
Keep the lyophilised vial sealed and protected from light and moisture. Short-term storage at 2–8°C is fine; for long-term storage keep it at −20°C and avoid repeated freeze-thaw cycles. After reconstitution, store the solution refrigerated at 2–8°C and use it within 28 days. Let a cold vial reach room temperature before opening it so condensation does not form on the powder.

Where can I buy GLOW in Australia?
Directly from Omega Peptides Australia. Stock is held domestically, orders placed before 12pm are dispatched the same day, and every batch is tested by Janoshik Analytical with the certificate published in our COA library. GLOW can be ordered on this page or browsed with the rest of our research peptides in Australia, including KLOW, the GLOW Peptide Bundle and the individual GHK-Cu, BPC-157 and TB-500 vials.

What does GLOW cost in Australia?
GLOW is $139.99 for a 70mg vial, or about $2.00 per mg of total peptide. The GLOW Peptide Bundle, which supplies the same three peptides as separate vials, is $189.99, and buying the individual vials would cost $289.97. KLOW, the four-peptide version with KPV, is $149.99 for 80mg.

How do I get GLOW online in Australia?
Add the 70mg vial to your cart, add bacteriostatic water if required, and complete checkout. Orders ship from within Australia with tracked domestic delivery and discreet, unbranded packaging. Orders placed before 12pm on a business day are dispatched the same day, and later orders leave the next business day.

Is GLOW legal in Australia?
Omega Peptides Australia supplies GLOW strictly for lawful in-vitro laboratory research. It is not approved by the TGA for human or veterinary use and is not sold as a medicine or supplement. Purchasers are responsible for ensuring their intended use complies with all applicable laws.

Should a laboratory choose the GLOW 70mg vial or the GLOW bundle of separate vials?
Choose the single 70mg vial when the study will use all three peptides together at the fixed 50:10:10 ratio, because it needs one reconstitution and costs less per mg. Choose the GLOW Peptide Bundle when each compound must be prepared at its own concentration, when single-compound controls are needed. Both are COA-verified.

Is GLOW peptide available in Australia?
Yes. Omega Peptides Australia holds the GLOW 70mg blend in Australian stock as a research-grade lyophilised vial, COA verified, with same-day dispatch before 12pm.

Where can I buy the GLOW blend in Australia?
From an Australian research peptide supplier with domestic stock. Omega Peptides Australia ships GLOW from within Australia on tracked delivery.

⚠ For in-vitro research and laboratory use only. Not for human or veterinary use.